USE OF NOVEL TRICHOMONACIDAL MOLECULES

The present invention relates to novel chemical compounds of formula I with a structure different from nitroimidazoles, and to equally novel uses thereof for the treatment of trichomoniasis, making said compounds useful for application by means of pharmaceutical compositions. Also, the administratio...

Full description

Saved in:
Bibliographic Details
Main Authors BENITEZ CARDOZA, Claudia Guadalupe, ORTEGA LÓPEZ, Jaime, ARROYO VERÁSTEGUI, Rossana, GARCÍA GUTIERREZ, Ponciano, BRIEBA DE CASTRO, Luis Gabriel, ROJO DOMÍNGUEZ, Arturo, VIQUE SÁNCHEZ, José Luis
Format Patent
LanguageEnglish
French
Spanish
Published 12.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel chemical compounds of formula I with a structure different from nitroimidazoles, and to equally novel uses thereof for the treatment of trichomoniasis, making said compounds useful for application by means of pharmaceutical compositions. Also, the administration of said compounds does not cause adverse side effects in comparison with compounds widely known in the field, such as metronidazole. La presente invención describe nuevos compuestos químicos de fórmula (I): fórmula (I) con estructura diferente a los nitroimidazoles, y sus usos igualmente novedosos para el tratamiento de la tricomoniasis, lo que los hace útiles para aplicarse mediante composiciones farmacéuticas. Así mismo, la administración de dichos compuestos, no causan efectos secundarios adversos en comparación con compuestos ampliamente conocidos en el arte, como por ejemplo, metronidazol. La présente invention concerne de nouveaux composés chimiques de formule I : I présentant une structure différente des nitroimidazoles, ainsi que leurs utilisations également nouvelles pour le traitement de la trichomonose, les rendant utiles pour une application au moyen de compositions pharmaceutiques. De plus, l'administration de ces composés ne provoque pas d'effets secondaires indésirables par comparaison à des composés amplement connus dans l'état de la technique, comme par exemple le métronidazol.
Bibliography:Application Number: WO2016IB56002